Variant Annotation ID	Variant/Haplotypes	Drug(s)	Phenotype Category	Significance	Sentence	Allele Of Frequency In Cases	Allele Of Frequency In Controls	P Value	Ratio Stat Type	Ratio Stat	Confidence Interval Start	Confidence Interval Stop	ref	alt
1449004938	rs1695	cyclophosphamide	Efficacy	no	Genotypes AG + GG is associated with decreased response to cyclophosphamide in people with Lupus Nephritis as compared to genotype AA.	G	G	= 0.03	OR	2.8	1.15	16.9	G	G
1185234906	rs1803274	rivastigmine	Efficacy	yes	Genotypes CT + TT is associated with decreased response to rivastigmine in people with Alzheimer Disease as compared to genotype CC.	C	T	= 0.016	OR	0.35	0.14	0.87	C	T
1449181943	rs8636	amisulpride	Efficacy	yes	Genotype CT is associated with increased response to amisulpride in people with Schizophrenia as compared to genotypes CC + TT.	C	C	= 0.027	OR	3.97	1.42	11.11	C	C
1449181943	rs8636	amisulpride	Efficacy	yes	Genotype CT is associated with increased response to amisulpride in people with Schizophrenia as compared to genotypes CC + TT.	C	C	= 0.027	OR	3.97	1.42	11.11	C	C
1449181943	rs8636	amisulpride	Efficacy	yes	Genotype CT is associated with increased response to amisulpride in people with Schizophrenia as compared to genotypes CC + TT.	C	C	= 0.053	OR	2.91	1.2	7.09	C	C
1449181943	rs8636	amisulpride	Efficacy	yes	Genotype CT is associated with increased response to amisulpride in people with Schizophrenia as compared to genotypes CC + TT.	C	C	= 0.053	OR	2.91	1.2	7.09	C	C
1444843016	rs10305420	liraglutide	Efficacy	yes	Genotypes CT + TT are associated with decreased response to liraglutide in women with Obesity and Polycystic Ovary Syndrome as compared to genotype CC.	C	T	= 0.025	OR	0.27	0.09	0.85	C	T
1184166985	rs6822844	rituximab	Efficacy	yes	Genotype GG is associated with increased response to rituximab in people with Autoimmune Diseases as compared to genotype GT.	G	G	= 0.024	OR	3.53	1.06	11.64	G	G
1184166985	rs6822844	rituximab	Efficacy	yes	Genotype GG is associated with increased response to rituximab in people with Autoimmune Diseases as compared to genotype GT.	G	G	= 0.024	OR	3.53	1.06	11.64	G	G
1184166985	rs6822844	rituximab	Efficacy	yes	Genotype GG is associated with increased response to rituximab in people with Autoimmune Diseases as compared to genotype GT.	G	G	= 0.683	OR	1.0	0.02	10.67	G	G
1184166985	rs6822844	rituximab	Efficacy	yes	Genotype GG is associated with increased response to rituximab in people with Autoimmune Diseases as compared to genotype GT.	G	G	= 0.683	OR	1.0	0.02	10.67	G	G
1444842903	rs6923761	liraglutide	Efficacy	no	Genotypes AA + AG are associated with increased response to liraglutide in women with Obesity and Polycystic Ovary Syndrome as compared to genotype GG.	A	G	= 0.058	OR	3.06	0.96	9.74	A	G
1448266279	rs6878291	platinum	Efficacy	yes	Genotype GG is associated with decreased response to platinum in people with Carcinoma, Non-Small-Cell Lung as compared to genotype AA.	G	G	= 0.001	OR	2.04	1.35	3.07	G	G
1448102401	rs4291	sertraline	Efficacy	no	Genotype TT is not associated with response to sertraline in people with Depressive Disorder.	T	T	= 0.803	OR	1.41	0.84	2.53	T	T
1448266217	rs12995526	methotrexate	Efficacy	yes	Genotypes CT + TT is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.	C	C	= 0.001	OR	0.23	0.1	0.53	C	C
1448266210	rs7563206	methotrexate	Efficacy	yes	Genotypes CT + TT is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.	C	C	< 0.001	OR	0.2	0.09	0.46	C	C
1184166980	rs6822844	rituximab	Efficacy	yes	Genotype GG is associated with increased response to rituximab in people with Lupus Erythematosus, Systemic as compared to genotype GT.	G	G	= 0.016	OR	6.43	1.42	21.07	G	G
1184166980	rs6822844	rituximab	Efficacy	yes	Genotype GG is associated with increased response to rituximab in people with Lupus Erythematosus, Systemic as compared to genotype GT.	G	G	= 0.016	OR	6.43	1.42	21.07	G	G
